Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000999

Drug Information
NameSR46349B    
Synonyms(E)-but-2-enedioic acid; 4-[(E)-3-(2-dimethylaminoethyloxyamino)-3-(2-fluorophenyl)prop-2-enylidene]cyclohexa-2,5-dien-1-one; 4-((3Z)-3-(2-Dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate; 2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-, O-(2-(dimethylamino)ethyl)oxime, (Z,E)-, (E)-2-butenedioate (2:1) (salt); SR 46349B; CID6438382; SR-46349B; Eplivanserin fumarate; AC1O5PLB; 130580-02-8; LS-184149; SR 46349    
CompanySanofi-Aventis    
IndicationSleep Initiation and Maintenance Disorders; Primary Insomnia; SchizophreniaPhase III completed    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
PubChem Compound IDCID 6438382.    
PubChem Substance IDSID 698346.    
ClinicalTrials.govNCT00679900;    
Target5-hydroxytryptamine receptor 2ABinder[1]
5-hydroxytryptamine receptor 2AMultitarget[1]
5-hydroxytryptamine receptor 2CBinder[1]
5-hydroxytryptamine receptor 2CMultitarget[1]
Ref 1The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543